{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T21:18:46Z","timestamp":1769116726489,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12094-017-1742-y","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T08:13:07Z","timestamp":1503994387000},"page":"1400-1408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Long-term cardiovascular complications in stage I seminoma patients"],"prefix":"10.1007","volume":"19","author":[{"given":"A.","family":"Terbuch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Posch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. M.","family":"Annerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bauernhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Szkandera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. C.","family":"Hutterer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Pummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Partl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Kapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"St\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-5401","authenticated-orcid":false,"given":"A.","family":"Gerger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Stotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"1742_CR1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/annonc\/mds579","volume":"24","author":"J Beyer","year":"2013","unstructured":"Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, et al. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol. 2013;24:878\u201388.","journal-title":"Ann Oncol"},{"key":"1742_CR2","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s12094-016-1566-1","volume":"12","author":"J Aparicio","year":"2016","unstructured":"Aparicio J, Terrasa J, Dur\u00e1n I, Germ\u00e0-Lluch JR, Giron\u00e9s R, Gonz\u00e1lez-Billalabeitia E, et al. SEOM clinical guidelines for the management of germ cell testicular cancer (2016). Clin Transl Oncol. 2016;12:1187\u201396.","journal-title":"Clin Transl Oncol"},{"key":"1742_CR3","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00345-015-1492-9","volume":"33","author":"A Bilici","year":"2015","unstructured":"Bilici A, Ozturk T, Turkmen E, Odabas H, Cihan S, Selcukbiricik F, et al. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology. World J Urol. 2015;33:1613\u201322.","journal-title":"World J Urol"},{"key":"1742_CR4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12094-008-0272-z","volume":"10","author":"A Flaquer","year":"2008","unstructured":"Flaquer A, Alvarez A, Sanchez SM. Role of radiotherapy in organ-sparing treatment of seminoma. Clin Transl Oncol. 2008;10:679\u201381.","journal-title":"Clin Transl Oncol"},{"key":"1742_CR5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/andr.280","volume":"3","author":"G Cohn-Cedermark","year":"2015","unstructured":"Cohn-Cedermark G, Stahl O, Tandstad T, Swenoteca. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors\u2014a review and the SWENOTECA experience. Andrology. 2015;3:102\u201310.","journal-title":"Andrology."},{"key":"1742_CR6","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","volume":"30","author":"HS Haugnes","year":"2012","unstructured":"Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydoy M, Oldenburg J, et al. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol. 2012;30:3752\u201363.","journal-title":"J Clin Oncol"},{"key":"1742_CR7","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1200\/JCO.2011.35.5669","volume":"29","author":"RA Moore","year":"2011","unstructured":"Moore RA, Adel N, Riedel E, Bhutani M, Feldmann DR, Tabbara NE, et al. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis. J Clin Oncol. 2011;29:3466\u201373.","journal-title":"J Clin Oncol"},{"key":"1742_CR8","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1200\/JCO.2006.10.5296","volume":"25","author":"AW Belt-Dusebout van den","year":"2007","unstructured":"van den Belt-Dusebout AW, de Wit R, Gietema JA, Horenblas S, Louwman MW, Ribot JG, et al. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol. 2007;25:4370\u20138.","journal-title":"J Clin Oncol"},{"key":"1742_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/bjc.2013.226","volume":"109","author":"PM Willemse","year":"2013","unstructured":"Willemse PM, Burggraaf J, Hamdy NA, Weijl NI, Vossen CY, van Wulften L, et al. Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors. Br J Cancer. 2013;109:60\u20137.","journal-title":"Br J Cancer"},{"key":"1742_CR10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1200\/JCO.2004.05.205","volume":"22","author":"GK Zagars","year":"2004","unstructured":"Zagars GK, Ballo MT, Lee AK, Strom SS. Mortality after cure of testicular seminoma. J Clin Oncol. 2004;22:640\u20137.","journal-title":"J Clin Oncol"},{"key":"1742_CR11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1200\/JCO.2003.04.173","volume":"21","author":"RA Huddart","year":"2003","unstructured":"Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, et al. Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol. 2003;21:1513\u201323.","journal-title":"J Clin Oncol"},{"key":"1742_CR12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1442-2042.2008.02066.x","volume":"15","author":"J Ishioka","year":"2008","unstructured":"Ishioka J, Fujii Y, Kageyama Y, Fukuda H, Higashi Y, Kihara K. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors. Int J Urol. 2008;15:642\u20135.","journal-title":"Int J Urol"},{"key":"1742_CR13","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1016\/j.ejca.2010.08.004","volume":"46","author":"T Wethal","year":"2010","unstructured":"Wethal T, Haugnes HS, Kjekshus J, Smastuen MC, Ueland T, Aukrust P, et al. C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors? Eur J Cancer. 2010;46:3425\u201333.","journal-title":"Eur J Cancer"},{"key":"1742_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2005.04.003","volume":"76","author":"W Majewski","year":"2005","unstructured":"Majewski W, Majewski S, Maciejewski A, Kolosza Z, Tarnawski R. Adverse effects after radiotherapy for early stage (I, IIa, IIb) seminoma. Radiother Oncol. 2005;76:257\u201363.","journal-title":"Radiother Oncol"},{"key":"1742_CR15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1200\/JCO.2005.08.003","volume":"23","author":"WG Jones","year":"2005","unstructured":"Jones WG, Fossa SD, Mead GM, Roberts JT, Sokal M, Horwich A, et al. Randomized trial of 30 versus 20\u00a0Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328). J Clin Oncol. 2005;23:1200\u20138.","journal-title":"J Clin Oncol"},{"key":"1742_CR16","first-page":"356","volume":"140","author":"R Cathomas","year":"2010","unstructured":"Cathomas R, Helbling D, Stenner F, Rothermundt C, Rentsch C, Shahin O, et al. Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort. Swiss Med Wkly. 2010;140:356\u201369.","journal-title":"Swiss Med Wkly"},{"key":"1742_CR17","unstructured":"Schmoll HJ, Hoffken K, Possinger K. Kompendium Internistische Onkologie. 1999."},{"key":"1742_CR18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2006.08.4889","volume":"25","author":"GJ Rustin","year":"2007","unstructured":"Rustin GJ, Mead GM, Stenning SP, Vasey PA, Aass N, Huddart RA, et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197\u2014the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol. 2007;25:1310\u20135.","journal-title":"J Clin Oncol"},{"key":"1742_CR19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1102\/1470-7330.2007.0023","volume":"7","author":"SA Sohaib","year":"2007","unstructured":"Sohaib SA, Husband J. Surveillance in testicular cancer: who, when, what and how? Cancer Imaging. 2007;7:145\u20137.","journal-title":"Cancer Imaging"},{"key":"1742_CR20","doi-asserted-by":"crossref","unstructured":"Souchon R, Hartmann M, Krege S, Lorch A, Mayer F, De Santis M, et al. Interdisciplinary evidence-based recommendations for the follow-up of early stage seminomatous testicular germ cell cancer patients. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft\u2026 [et al] 2011;187:158\u2013166.","DOI":"10.1007\/s00066-010-2227-x"},{"key":"1742_CR21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1160\/TH15-09-0758","volume":"115","author":"F Posch","year":"2016","unstructured":"Posch F, Riedl J, Reitter EM, Kaider A, Zielinski C, Pabinger I, et al. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model. Thromb Haemost. 2016;115:817\u201326.","journal-title":"Thromb Haemost"},{"key":"1742_CR22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(05)66984-X","volume":"366","author":"RT Oliver","year":"2005","unstructured":"Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005;366:293\u2013300.","journal-title":"Lancet"},{"key":"1742_CR23","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1200\/JCO.2009.26.4655","volume":"29","author":"RT Oliver","year":"2011","unstructured":"Oliver RT, Mead GM, Rustin GJ, Joffe JK, Aass N, Coleman R, et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19\/EORTC 30982 study (ISRCTN27163214). J Clin Oncol. 2011;29:957\u201362.","journal-title":"J Clin Oncol"},{"key":"1742_CR24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/annonc\/mdm540","volume":"19","author":"T Powles","year":"2008","unstructured":"Powles T, Robinson D, Shamash J, Moller H, Tranter N, Oliver T. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol. 2008;19:443\u20137.","journal-title":"Ann Oncol"},{"key":"1742_CR25","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","volume":"367","author":"S Kaptoge","year":"2012","unstructured":"Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367:1310\u201320.","journal-title":"N Engl J Med"},{"key":"1742_CR26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1177\/2047487316638201","volume":"23","author":"P Graversen","year":"2016","unstructured":"Graversen P, Abildstrom SZ, Jespersen L, Borglykke A, Prescott E. Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study. Eur J Prev Cardiol. 2016;23:1546\u201356.","journal-title":"Eur J Prev Cardiol."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-017-1742-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-017-1742-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T03:55:48Z","timestamp":1507607748000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-017-1742-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1742"],"URL":"https:\/\/doi.org\/10.1007\/s12094-017-1742-y","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]}}}